Recent Advancements in Non-Small Cell Lung Cancer

Bilal Piperdi, MD, Associate Professor of Clinical Medicine, Department of Medicine (Oncology), Albert Einstein College of Medicine, discusses the recent advancements in non-small cell lung cancer treatment and what the future might bring.

Clinical Pearls:

• There have been improvements in molecular testing
• Physicians have learned that it is not just the histology that determines the biology of these patients; it is different mutations that define the biology of this disease
• More advances in molecular testing would allow for clinicians to test for multiple mutations at a time, including some of the uncommon mutations
• The challenge in the future will be learning how the different mutations interact and what targets can better treat the cancer